NFKB1 and familial pancreatic carcinoma: On the other hand, Pan et al. recently reported that there was no significant correlation between basal NF-κB activity and gemcitabine sensitivity, and that gemcitabine did not activate NF-κB in pancreatic cancer cells [5].